Binding of tissue plasminogen activator to human umbilical vein endothelial cells.

[1]  P. Wallén,et al.  In vivo metabolism of human tissue-type plasminogen activator. , 2009, Scandinavian journal of haematology.

[2]  Gary Halvorson,et al.  Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Verstraete M, Bory M, Erbel R, et al Lancet 842–847 Apr 13, 1985 , 1985 .

[3]  L. Häggroth,et al.  Turnover of tissue plasminogen activator in normal and hepatectomized rabbits. , 1985, Thrombosis research.

[4]  R. W. Brower,et al.  RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator , 1985, The Lancet.

[5]  H. Berger,et al.  Catabolism of human tissue plasminogen activator in mice. , 1985, Blood.

[6]  B E Sobel,et al.  Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. , 1984, Circulation.

[7]  E. Kruithof,et al.  Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. , 1984, Blood.

[8]  F. Van de Werf,et al.  Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. , 1984, The New England journal of medicine.

[9]  B. Sobel,et al.  Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. , 1984, Circulation.

[10]  B. Wiman,et al.  Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. , 1983, Thrombosis research.

[11]  L. Häggroth,et al.  Human extrinsic plasminogen activator fibrinolytic properties and neutralization in vivo. , 1983, Thrombosis research.

[12]  C. Korninger,et al.  Turnover of Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits , 1981, Thrombosis and Haemostasis.

[13]  C. Korninger,et al.  Neutralization of Human Extrinsic (Tissue-Type) Plasminogen Activator in Human Plasma: No Evidence for a Specific Inhibitor , 1981, Thrombosis and Haemostasis.

[14]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[15]  C. Steer,et al.  Studies on a mammalian hepatic binding protein specific for asialoglycoproteins. Evidence for receptor recycling in isolated rat hepatocytes. , 1980, The Journal of biological chemistry.

[16]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[17]  K. V. von Kaulla,et al.  Dissimilarity of human vascular plasminogen activator and human urokinase. , 1971, The Journal of laboratory and clinical medicine.

[18]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[19]  D. Rijken,et al.  Immunological characterization of plasminogen activator activities in human tissues and body fluids. , 1981, The Journal of laboratory and clinical medicine.